Search

everythinglearnresearchcommunity

for

Search:↓

A 12-year-old boy with PAIS successfully developed male characteristics using high-dose testosterone and anastrozole.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

A boy with a rare form of early puberty caused by a new gene mutation responded well to treatment aimed at reducing testosterone and preserving adult height.

Two teenage boys lost hair after taking a drug for growth, which was not a known side effect for kids.

The therapies improved ejaculation disorders and sexual function in middle-aged men.

Hair loss is a common side effect of hormone treatments for cancer.

High testosterone levels can harm fertility by disrupting the LIF signaling pathway in the uterus.

Androgens and estrogens are crucial for insulin secretion in males.

High doses of testosterone disrupt hormone levels and receptor expression in the uterus, affecting fertility.

Testosterone in our bodies helps increase insulin secretion from the pancreas.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Honey and bee pollen can help reduce menopausal symptoms in breast cancer patients.

PFS affects some women, steroids easily bought online, hypogonadism info unreliable, low testosterone linked to CVD.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.

Low-dose oral minoxidil improved hair growth when topical treatments failed.

Testosterone helps human pancreatic cells increase insulin release.

Centratherum anthelminticum seed extract effectively treats Polycystic Ovary Syndrome in rats.

A woman experienced fluctuating thyroid conditions and eye disease, but her symptoms improved with treatment.

Exemestane may protect bones by stimulating osteoblast growth through androgen-related pathways.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Using steroids can increase the risk of heart problems.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

There is no significant link between insulin resistance and certain hair disorders like idiopathic hirsutism and androgenic alopecia.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.